BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2025.
World J Psychiatry. Oct 19, 2025; 15(10): 107298
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.107298
Table 1 Baseline characteristics of study participants by treatment group, n (%)
Characteristics
Sham-tDCS (n = 101)
Active-tDCS (n = 100)
P value
Sex0.332
Male74 (73.3)67 (67.0)
Female27 (26.7)33 (33.0)
Age (year), median (IQR)72 (69-76)72 (69-75)0.877
BMI (kg/m2), mean ± SD22.79 ± 2.6722.43 ± 2.520.332
ASA score (%)0.472
II81 (80.2)76 (76.0)
III20 (19.8)24 (24.0)
History of smoking36 (35.6)40 (40.0)0.524
History of anesthesia33 (32.7)34 (34.0)0.842
MMSE score, median (IQR)26 (25-28)26 (25-28)0.144
Hemoglobin (g/L), median (IQR)125 (111.5-139)123 (115.5-132)0.680
Albumin (g/L), median (IQR)39.14 (3.64) 39.25 (3.52) 0.827
Self-Rating Depression Scale, median (IQR)28 (26-29)28 (26.25-30)0.353
Self-Rating Anxiety Scale, median (IQR)28 (27-30)28.5 (27-30.75)0.104
Athens Insomnia Scale, median (IQR)1 (1-2)1 (1-2.75)0.797
Age-adjusted Charlson Comorbidity Index, median (IQR)3 (3-4)3 (2-3)0.327
Education level0.657
Illiteracy17 (16.8)21 (21.0)
Elementary school45 (44.6)43 (43.0)
Middle school28 (27.7)28 (28.0)
High school10 (9.9)7 (7.0)
College graduate1 (1.0)1 (1.0)
Frailty0.204
Robust46 (45.5)58 (58.0)
Prefrail38 (37.6)30 (30.0)
Frail17 (16.8)12 (12.0)
Comorbidities0.728
Hypertension40 (39.6)44 (44.0)
Diabetes24 (23.8)19 (19.0)
Stroke24(23.8)22 (22.0)
Coronary heart disease4 (4.0)5 (5.0)
Type of operation0.867
Stomach44 (43.6)44 (44.0)
Rectum23 (22.8)28 (28.0)
Colon15 (14.9)11 (11.0)
Liver13 (12.9)11 (11.0)
Pancreaticoduodenum6 (5.9)6 (6.0)


Write to the Help Desk